Merit Medical Systems demonstrated strong financial performance with significant revenue and margin improvements, bolstered by strategic acquisitions and product growth. However, delays in reimbursement strategies and challenges in the Chinese market present headwinds. Despite these, the company maintains a positive outlook with strategic leadership changes and continued operational efficiency.

Company Guidance

During Merit Medical Systems' second quarter 2025 earnings call, the company provided updated financial guidance for the year. They reported total revenue of $382.5 million, reflecting a 13% year-over-year increase on a GAAP basis and 12.5% on a constant currency basis. The company noted a significant improvement in non-GAAP operating margin, which rose by nearly 109 basis points to a record 21.2%. Non-GAAP EPS grew by 10%, surpassing expectations, and free cash flow increased by 20% year-over-year to $70 million. Merit Medical's fiscal year 2025 guidance was updated to reflect a GAAP net revenue growth of 10% to 11%, with a constant currency revenue growth expectation of 9.7% to 10.6%. The company also revised its non-GAAP diluted EPS guidance to a range of $3.52 to $3.72, increased from the prior range of $3.28 to $3.41.

Strong Revenue Growth

Merit Medical Systems reported a total revenue of $382.5 million for Q2 2025, marking a 13% increase year-over-year on a GAAP basis and 12.5% on a constant currency basis, exceeding expectations.

Improved Operating Margin

The company achieved a non-GAAP operating margin of 21.2%, an increase of 109 basis points year-over-year, the highest in the company's public history.

Free Cash Flow Increase

Merit generated $70 million of free cash flow, reflecting a 20% increase year-over-year, contributing to a strong financial position.

Cardiac Intervention Growth

Cardiac intervention product sales increased 23%, driven by internal product developments and strategic acquisitions.

Strategic Acquisition

Acquisition of Biolife Delaware, L.L.C. for $120 million, expanding Merit's portfolio in hemostatic solutions.

CEO Succession

Appointment of Martha Aronson as new President and CEO, effective October 3, 2025, to lead the next stage of growth.

Merit Medical Systems (MMSI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MMSI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 23, 2025	2025 (Q3)	0.83 / -	0.86	―	―	―
Jul 30, 2025	2025 (Q2)	0.85 / 1.01	0.92	9.78% (+0.09)
Apr 24, 2025	2025 (Q1)	0.75 / 0.86	0.77	11.69% (+0.09)
Feb 25, 2025	2024 (Q4)	0.83 / 0.93	0.81	14.81% (+0.12)
Oct 30, 2024	2024 (Q3)	0.80 / 0.86	0.75	14.67% (+0.11)
Aug 01, 2024	2024 (Q2)	0.87 / 0.92	0.81	13.58% (+0.11)
Apr 30, 2024	2024 (Q1)	0.71 / 0.77	0.64	20.31% (+0.13)
Feb 28, 2024	2023 (Q4)	0.77 / 0.81	0.79	2.53% (+0.02)
Oct 26, 2023	2023 (Q3)	0.65 / 0.75	0.64	17.19% (+0.11)
Jul 25, 2023	2023 (Q2)	0.75 / 0.81	0.73	10.96% (+0.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MMSI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$82.96	$84.86	+2.29%
Apr 24, 2025	$94.67	$94.61	-0.06%
Feb 25, 2025	$102.03	$100.45	-1.55%
Oct 30, 2024	$94.90	$98.66	+3.96%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Merit Medical Systems (MMSI) report earnings?

Merit Medical Systems (MMSI) is schdueled to report earning on Oct 23, 2025, After Close (Confirmed).

What is Merit Medical Systems (MMSI) earnings time?

Merit Medical Systems (MMSI) earnings time is at Oct 23, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MMSI EPS forecast?

MMSI EPS forecast for the fiscal quarter 2025 (Q3) is 0.83.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing